Bioventus Inc. — Director's Dealing 2025

Nov 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2025-11-07

Reporting Person: McMurry-Heath Michelle (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-07	Class A Common Stock	S	17701	$7.4151	Disposed	56997	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.36 to $7.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.